Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India
TLDR
E. coli was the predominant bacterial pathogen of community acquired UTIs in Aligarh, India and an increasing resistance to Co-trimoxazole and production of extended spectrum β-lactamase among UTI pathogens in the community was demonstrated.Abstract:
Urinary tract infections (UTIs) remain the common infections diagnosed in outpatients as well as hospitalized patients. Current knowledge on antimicrobial susceptibility pattern is essential for appropriate therapy. Extended-Spectrum beta-Lactamase (ESBL) producing bacteria may not be detected by routine disk diffusion susceptibility test, leading to inappropriate use of antibiotics and treatment failure. The aim of this study was to determine the distribution and antibiotic susceptibility patterns of bacterial strains isolated from patients with community acquired urinary tract infections (UTIs) at Aligarh hospital in India as well as identification of ESBL producers in the population of different uropathogens. Urinary isolates from symptomatic UTI cases attending to the JN Medical College and hospital at Aligarh were identified by conventional methods. Antimicrobial susceptibility testing was performed by Kirby Bauer's disc diffusion method. Isolates resistant to third generation cephalosporin were tested for ESBL production by double disk synergy test method. Of the 920 tested sample 100 samples showed growth of pathogens among which the most prevalent were E. coli (61%) followed by Klebsiella spp (22%). The majority (66.66%) of the isolates were from female while the remaining were from male. Among the gram-negative enteric bacilli high prevalence of resistance was observed against ampicillin and co-trimoxazole. Most of the isolates were resistant to 4 or more number of antibiotics. Forty two percent of isolates were detected to produce ESBL among which 34.42 % were E. coli isolates. This study revealed that E. coli was the predominant bacterial pathogen of community acquired UTIs in Aligarh, India. It also demonstrated an increasing resistance to Co-trimoxazole and production of extended spectrum β-lactamase among UTI pathogens in the community. This study is useful for clinician in order to improve the empiric treatment.read more
Citations
More filters
Journal ArticleDOI
Antimicrobial activity of five herbal extracts against multi drug resistant (MDR) strains of bacteria and fungus of clinical origin.
Rosina Khan,Barira Islam,Mohd. Akram,Shazi Shakil,Anis Ahmad,S. Manazir Ali,Mashiatullah Siddiqui,Asad U. Khan +7 more
TL;DR: This study concludes that A. nilotica, C. zeylanicum and S. aromaticum can be used against multidrug resistant microbes causing nosocomial and community acquired infections.
Journal ArticleDOI
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
TL;DR: The continued increase in fluoroquinolone resistance affects patient management and necessitates changes in some guidelines, for example, treatment of urinary tract, intra-abdominal, skin and skin structure infections, and traveller's diarrhea, or even precludes the use in indications like sexually transmitted diseases and enteric fever.
Journal ArticleDOI
Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009)
TL;DR: Bacteria isolated from females were less resistant than those isolated from males and this difference increased with the patient age, but the fluoroquinolones should not be suitable to treat male infections and the trimethoprim-sulfamethoxazole shall not be used in the treatment of UTI at this level.
Journal ArticleDOI
Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.
TL;DR: This review explores the molecular understanding of aminoglycoside action and resistance with an aim to minimize the spread of resistance.
Journal ArticleDOI
Urinary Tract Infections
TL;DR: Efforts should be made not to detect or treat asymptomatic bacteriuria and funguria; to ensure an appropriate duration of therapy for symptomatic infections; and to limit the use of broad-spectrum agents, especially fluoroquinolones, if narrower spectrum agents are available.
References
More filters
Performance standards for antimicrobial susceptibility testing
TL;DR: The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards.
Book
Principles and Practice of Infectious Diseases
TL;DR: This updated and expanded edition now offers 297 chapters that cover the basic principles of diagnosis and management, major clinical syndromes, all important pathogenic microbes and the diseases they cause, plus a number of specialised topics useful to the practitioner.
Journal ArticleDOI
Characterization of Pseudomonas aeruginosa Isolates: Occurrence Rates, Antimicrobial Susceptibility Patterns, and Molecular Typing in the Global SENTRY Antimicrobial Surveillance Program, 1997–1999
TL;DR: Europe was the only region to show a significant decline in beta-lactam and aminoglycoside susceptibility rates, and isolates showing unique ribogroups were found in Europe, Latin America, and the United States, but clonal spread was documented in several medical centers.
Journal ArticleDOI
Urinary Tract Infections in Females
TL;DR: Asymptomatic bacteriuria or asymPTomatic funguria may be limited to colonization of the urine without an apparent inflammatory response, and should be considered to be an asymptoma infection when accompanied by pyuria.